UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 14A
Proxy Statement Pursuant to Section 14(a) of the Securities
Exchange Act of 1934 (Amendment No. )
Filed by the Registrant ( )
Filed by a Party other than the Registrant (X)
Check the appropriate box:
( ) Preliminary Proxy Statement ( ) Confidential for Use of
the Commission Only (as
( ) Definitive Proxy Statement permitted by Rule
14a-6(e)(2))
(x) Definitive Additional Materials
( ) Soliciting Material Pursuant to (Section)240.14a-11(c) or
(Section)240.14a-12
______________________Novametrix Medical Systems, Inc._________________________
(Name of Registrant as Specified In Its Charter)
___________Paul A. Cote, on behalf of Novametrix 13D Shareholders Group______
(Name of Person(s) Filing Proxy Statement, if other than the
Registrant)
Payment of Filing Fee (Check the appropriate box):
( ) $125 per Exchange Act Rules 0-11(c)(1)(ii), 14a-6(i)(1),
14a-6(i)(2)
or item 22(a)(2) of Schedule 14A.
( ) $500 per each party to the contoversy pursuant to Exchange Act
Rule 14a-6(i)(3).
( ) Fee computed on table below per Exchange Act Rules 14a-6(i)(4)
and 0-11.
1) Title of each class of securities to which transaction
applies:
_________________________________________________________________
____________
2) Aggregate number of securities to which transaction applies:
_________________________________________________________________
____________
3) Per unit price or other underlying value of transaction
computed pursuant to Exchange Act Rule 0-11 (Set forth the
amount on which the filing fee is calculated and state how it
was determined):
_________________________________________________________________
____________
4) Proposed maximum aggregate value of transaction:
_________________________________________________________________
____________
5) Total fee paid:
_________________________________________________________________
____________
DEFINITIVE PROXY STATEMENT
